Form D · Biotechnology

Gut-Brain-Axis Therapeutics Inc.

Tempe, AZ · CIK 0001996678

Offering snapshot reported Oct 27, 2026 · SEC filing

Reported sold
$1.97M
Offering amount: $20M
Investors reported
22
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 31, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$983K$1.97MNov 6, 2025: $1,965,000.00Nov 6, 2025Oct 27, 2026: $1,965,000.00Oct 27, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 27, 2026Amendment$1,965,000$0vs Nov 6, 202522SEC filing
Nov 6, 2025Initial$1,965,000No comparison22SEC filing
Oct 10, 2023Initial$1,425,000No comparison23SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-563342

Source: Form D, filed Oct 27, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James B. Adams Director, Executive
Alexander Khorus Director
Alexander Khoruts Director
Rosa Krajalnik Brown Director
Rosa Krajmalnik Brown Director
Michael J. Sadowsky Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1340 E Vinedo Lane
Tempe, AZ, 85284